Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

39.30
Delayed Data
As of May 27
 +0.41 / +1.05%
Today’s Change
36.00
Today|||52-Week Range
51.74
-12.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Operating ActivitiesNet Income / Starting Line784.0M580.0M767.0M316.0M
 
 
 
 
 
Depreciation352.0M383.0M366.0M347.0M
 
 
 
 
 
Total Other Cash Flow-149.0M27.0M22.0M629.0M
 
 
 
 
 
Funds From Operations987.0M990.0M1.2B1.3B
 
 
 
 
 
Extraordinary Items----0.00-25.0M
 
 
Funds From/For Other Operating Expenses46.0M-205.0M327.0M1.4B
 
 
 
 
 
Net Cash Flow - Operating Activities941.0M1.2B828.0M-93.0M
 
 
 
 
 
 
InvestingIncrease In Investments-1.8B-570.0M-2.3B--
 
 
 
 
Decrease In Investments------446.0M
 
 
Capital Expenditures-216.0M-411.0M-248.0M-243.0M
 
 
 
 
 
Fixed Asset Disposal2.3B0.00-2.3B25.0M
 
 
 
 
Net Assets From Acquisitions ---231.0M0.00--
 
 
Other Investing - Uses0.000.000.00-2.0M
 
 
Other Investing - Sources15.0M15.0M9.0M0.00
 
 
 
 
Net Cash Flow Investing242.0M-1.2B1.6B226.0M
 
 
 
 
 
 
FinancingShort Term Borrowings-47.0M-501.0M738.0M-583.0M
 
 
 
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction-23.0M-3.0M-21.0M-7.0M
 
 
 
 
 
Net Proceeds Stock Sale57.0M50.0M51.0M87.0M
 
 
 
 
 
Common Preferred Redeemed-1.0M-2.0M-888.0M-519.0M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-360.0M-359.0M-360.0M-385.0M
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.0017.0M25.0M
 
 
 
Net Cash Flow - Financing-374.0M-815.0M-497.0M-1.4B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash13.0M-99.0M-28.0M-368.0M
 
 
 
 
 
 
Net Change In Cash809.0M-817.0M1.9B-1.3B